Top Markets
Coin of the day
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Rank in Stocks #32060
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Share Price
$0.02187539
Market Cap
$11.28M
Change (1 day)
0.00%
Change (1 year)
-54.99%
Country
HK
Trade Joyzyme Group Limited (8622)

Category

P/B ratio for Joyzyme Group Limited (8622)
P/B ratio as of 2026 TTM: 0
According to Joyzyme Group Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Joyzyme Group Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors